PHOSPHOLIPIDS AS CASPASE INHIBITOR PRODRUGS

Details for Australian Patent Application No. 2003211052 (hide)

Owner VERTEX PHARMACEUTICALS INCORPORATED

Inventors MORTIMORE, Michael; GOLEC, Julian, M., C.

Pub. Number AU-A-2003211052

PCT Number PCT/US03/04457

PCT Pub. Number WO2003/068242

Priority 60/355,889 11.02.02 US

Filing date 11 February 2003

Wipo publication date 4 September 2003

International Classifications

A61K 031/685

C07D 209/26 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/34 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 409/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 271/06 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61P 037/06 Drugs for immunological or allergic disorders

C07C 237/36 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 237/40 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07K 005/06 Peptides having up to four amino acids in a fully defined sequence

C07F 009/10 Compounds containing elements of the 5th Group of the Periodic System

C07K 005/02 Peptides having up to four amino acids in a fully defined sequence

C07D 209/94 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/86 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 239/90 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/355,889 11.02.02 US

2 October 2003 Application Open to Public Inspection

  Published as AU-A-2003211052

28 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003211053-SYSTEM AND METHOD FOR VIDEOCONFERENCING ACROSS NETWORKS SEPARATED BY A FIREWALL

2003211051-DRUG DOSE-FORM AND METHOD OF MANUFACTURE